Most of the EU are saying they are for patent waivers, except Germany, according to the article, but are annoyed that the US changed their position on COVAX, which makes a lot of sense since the US still hasn’t agreed to participate in COVAX and is stockpiling 2x as many doses as we could possibly need. In this way, the US suddenly being pro patent waivers is disingenuous, since patent waivers would still mean that the US hasn’t committed to the global vaccination effort while COVAX partners would foot the bill with whatever alleged benefit patent waivers bring in reducing costs.
Most vaccines aren’t actually produced in the country of origin, or even by the developer, but are actually outsourced to companies in places like India, who is producing the majority of Covid 19 vaccines for the world (ironically, their outbreak is supposedly what changed the US’s mind, and they stopped exporting vaccines two months ago).
If I understand correctly (please correct me if I’m wrong), from there they’re sent to places like the US, where a regulatory body, like the FDA, determines if they’re safe.
If you read further down in the article, those defending patent rights are actually more concerned about patents surrounding things like manufacturing and storage techniques, which are beyond the scope of the patents for the vaccine themselves.
I would not put this much faith in big pharma
biontech and Pfizer are beholden to their shareholders, and while most manufacturers are selling vaccines at low prices now, they have every intention of raising prices in the coming months (Pfizer and their CEO have been very candid about this, as have others, with increases expected in September). Like I mentioned, Moderna claimed they’d waive patents back in October, yet here we are in May and there’s still no generic Moderna vaccine...
They could give a shit about these poorer countries, whom they often use as guinea pigs for new pharmaceuticals... As I mentioned above, vaccine (really all pharmaceutical) production is often outsourced to places like India, Malaysia, the Philippines... These countries are already more than capable of producing the vaccine themselves.
What patent waivers do is allow other manufacturers in poorer countries to produce and distribute vaccines royalty free/at cost, but that doesn’t really matter since the world’s vaccine producers are already at capacity. What’s needed is more buyers, more resources, and more facilities. The perils of just-in-time/LEAN production — the same reasons our hospitals were overwhelmed!
It’s a clusterfuck to say the least
Vaccinating the world will be tough. Here’s what intellectual property waivers can and can’t do.
www.vox.com